0000885590-14-000029.txt : 20140319 0000885590-14-000029.hdr.sgml : 20140319 20140319163319 ACCESSION NUMBER: 0000885590-14-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140317 FILED AS OF DATE: 20140319 DATE AS OF CHANGE: 20140319 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chai-Onn Robert Roswell CENTRAL INDEX KEY: 0001502213 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 14704301 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST CITY: LAVAL STATE: A8 ZIP: H7L 4A8 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2014-03-17 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001502213 Chai-Onn Robert Roswell 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, Gen. Couns. & Corp. Secy. Common Stock, no par value 2014-03-17 4 M 0 5000 6.45 A 28999 D Common Stock, no par value 2014-03-17 4 S 0 5000 141.72 D 23999 D Non-Qualified Stock 6.45 2014-03-17 4 M 0 5000 0 D 2008-08-09 2014-08-09 Common Shares, no par value 5000 20203 D This number represents options exercised and sold pursuant to a 10b5-1 trading plan. This number represents the weighted average sale price for all sales of common stock sold by the reporting officer pursuant to a 10b5-1 trading plan. Actual sale executions were in the range of $141.63 and $141.80. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price. The options vested one-fourth per year over four years starting from the date of grant with the first vest date falling on the first anniversary of the grant, the second vest date falling on the second anniversary of the grant, the third vest date falling on the third anniversary of the grant, and the fourth vest date falling fourth anniversary of the grant. by: Nicholas Zanoni for Robert Chai-Onn 2014-03-19